Defiance Daily Target 2X Long LLY ETF (LLYX)

Assets	$50.22M
Expense Ratio	1.32%
PE Ratio	n/a
Shares Out	5.97M
Dividend (ttm)	$0.70
Dividend Yield	4.44%
Ex-Dividend Date	Dec 30, 2025
Payout Frequency	n/a
Payout Ratio	n/a

Volume	161,987
Open	16.47
Previous Close	16.58
Day's Range	15.81 - 16.67
52-Week Low	9.60
52-Week High	28.44
Beta	n/a
Holdings	10
Inception Date	Aug 7, 2024

About LLYX

Fund Home Page

The Defiance Daily Target 2X Long LLY ETF (LLYX) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to provide 2x leveraged exposure to the daily share price movement of the Eli Lilly and Company (NYSE: LLY), less fees and expenses. LLYX was launched on Aug 7, 2024 and is issued by Defiance.

• Asset Class: Equity
• Category: Trading--Leveraged Equity
• Stock Exchange: NYSEARCA
• Ticker Symbol: LLYX
• ETF Provider: Defiance

Top Holdings

Name	Symbol	Weight
US DOLLARS	n/a	58.33%
ELI LILLY & CO SWAP MS	n/a	45.90%
LLY SWAP NOMURA	n/a	34.47%
ELI LILLY & CO SWAP CS	n/a	34.08%
ELI LILLY & CO SWAP MAREX	n/a	31.21%
ELI LILLY & CO SWAP BMO	n/a	30.39%
ELI LILLY & CO SWAP Cantor - L	n/a	28.61%
United States Treasury Bills 0%	B.0 04.23.26	16.28%
OTHER ASSETS AND LIABILITIES	n/a	14.37%
Cash Offset	n/a	-193.63%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 30, 2025	$0.70417	Dec 31, 2025

Performance

LLYX had a total return of -17.38% in the past year, including dividends. Since the fund's inception, the average annual return has been -20.42%.